Name: | peginterferon alfa-2a |
---|---|
PubChem Substance ID: | 3819816 |
Synonyms: |
Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl; Peginterferon alfa-2a; 198153-51-4; Peginterferon alfa-2a [INN]; Pegasys; 330464-33-0; Ro 25-8310/000
|
Name: | peginterferon alfa-2a |
---|---|
Name (isomeric): | DB00008 |
Drug Type: | biotech |
Brand: | Pegasys, Pegasys (Hoffman-La Roche Inc) |
Category: | Antineoplastic Agents, Immunomodulatory Agents, Antiviral Agents |
CAS number: | 198153-51-4 |
Indication: | For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
---|---|
Pharmacology: |
Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several ke...
show more » |
Mechanism of Action: |
Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcriptio...
show more » |
Half Life: | Terminal half life is 80 hours (range 50 to 140 hours). |
Affected organisms: | Humans and other mammals |
Food interaction: |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug interaction: |
|